Clopidogrel does not optimally inhibit platelet aggregation in patients undergoing percutaneous coronary intervention. Observations from the DEACON study

被引:0
|
作者
Saucedo, JF
Aude, W
Garza, L
机构
[1] Univ Oklahoma, HSC, Oklahoma City, OK USA
[2] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:10L / 11L
页数:2
相关论文
共 50 条
  • [31] ABO blood groups and platelet reactivity in patients with coronary artery disease undergoing percutaneous coronary intervention treated with clopidogrel
    Liu, M. L.
    Li, J. W.
    Yan, K. L.
    Yuan, J. Q.
    Zhao, X. Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [32] Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
    Yang, Bin
    Zheng, Chunyan
    Yu, Haichu
    Zhang, Rui
    Li, Shan
    Tan, Lijuan
    Leng, Min
    Cai, Shanglang
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2018, 47 (07) : 952 - 957
  • [33] CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
    Zeb, Shah
    Shah, Ibrahim
    Adil, Mohammad
    Ali, Jabar
    Jan, Hikmatullah
    Gul, Adnan Mahmood
    Hafizullah, Mohammad
    PAKISTAN HEART JOURNAL, 2016, 49 (03): : 107 - 112
  • [34] Clopidogrel 150 Mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention. Results from the Vasp-02 Randomized Study
    Aleil, Boris
    Jacquemin, Laurent
    De Poli, Fabien
    Zaehringer, Michel
    Collet, Jean-Philippe
    Montalescot, Gilles
    Cazenave, Jean-Pierre
    Dickele, Marie-Claude
    Monassier, Jean-Pierre
    Gachet, Christian
    CIRCULATION, 2008, 118 (18) : S820 - S820
  • [35] Clinical and genetic predictors of anti-platelet therapy selection in coronary artery disease patients undergoing percutaneous coronary intervention.
    Varunok, Nicholas
    Hamrick, Kasey
    Polasek, Melissa
    Lee, John Andrew
    Wells, Michael
    Cervantes, Alexandra
    Sriramoju, Vindhya B.
    Howell, Lucius
    Stouffer, George A.
    Lee, Craig
    PHARMACOTHERAPY, 2016, 36 (07): : E112 - E113
  • [36] 2c19*2 polymorphism and platelet aggregation in patients on clopidogrel after percutaneous coronary intervention
    Elshal, Abdallah Mohamed Abdelghany
    Youssof, Mahmoud Mohamed Abdou
    Amer, Maged Zaghloul Mohamed
    Younis, Gamal Othman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0F) : F11 - F11
  • [37] Accelerated inhibition of platelet activation and aggregation after administration of clopidogrel compared to ticlopidine in patients undergoing coronary intervention
    Altmann, C
    Haude, M
    Welge, D
    Vonnahme, J
    Vonnahme, J
    Wieneke, H
    Volbracht, L
    Erbel, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 32A - 32A
  • [38] Mean platelet volume in patients undergoing percutaneous coronary intervention
    Balta, Sevket
    Mikhailidis, Dimitri P.
    Kurtoglu, Ertugrul
    Demirkol, Sait
    PLATELETS, 2015, 26 (03) : 269 - 270
  • [39] Clopidogrel Resistance and Coronary, Artery Plaque Burden in Patients Undergoing Percutaneous Coronary Intervention
    Chirumamilla, Amala
    Maehara, Akiko
    Mintz, Gary S.
    Mehran, Roxana
    Caixeta, Adriano
    Brar, Somjot S.
    Iyengar, Srinivas
    Rabbani, Leroy
    Oveido, Carlos
    Fiscella, Damiana
    Sfakianakis, Konstantinos
    Kreps, Edward M.
    Collins, Michael B.
    Singh, Varinder
    Leon, Martin B.
    Stone, Gregg W.
    Moses, Jeffrey W.
    Dangas, George
    CIRCULATION, 2008, 118 (18) : S960 - S960
  • [40] On-Clopidogrel Platelet Reactivity in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Association with Patient Characteristics
    Gjermeni, Diona
    Vetter, Hannah
    Szabo, Sofia
    Anfang, Viktoria
    Hesselbarth, David
    Leggewie, Stefan
    Trenk, Dietmar
    Duerschmied, Daniel
    Bode, Christoph
    Olivier, Christoph
    CIRCULATION, 2021, 144